StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Thursday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.5 % Shares of BTX opened at $3.14 on Thursday. Brooklyn ImmunoTherapeutics has a twelve month low of $0.17 and a twelve month […]